Human Resources
Daiichi Sankyo Australia earns Family Inclusive Workplace Certification in record time since commencement of local operations

Human Resources: In a milestone for workplace inclusivity, Daiichi Sankyo Australia announced that the company has been certified as a Family Inclusive Workplace, affirming their commitment to fostering an environment that supports employees at all stages of life.
The certification, granted in adherence to the National Work + Family Standards developed by Family Friendly Workplaces and endorsed by UNICEF Australia, signifies Daiichi Sankyo’s dedication to upholding benchmark policies and practices. These encompass a broad spectrum, including flexible work practices, parental leave, family care, and overall employee wellbeing.
Natalie Down, Head of People & Culture at Daiichi Sankyo Australia, expressed the company’s core values and aspirations, stating, “As we build our culture and our team, we have been clear from the outset that we will craft a unique employee experience with embedded flexibility to support our people to be there in the moments that matter for their families – no matter what form their families take. We celebrate our recently announced Family Inclusive Workplace Certification as a vital building block to achieving this.”
Daiichi Sankyo, having commenced operations in Australia earlier this year, is on the brink of revolutionising cancer treatment with its proprietary DXd antibody drug conjugate (ADC) technology. Presently, the company is evaluating five ADCs in its oncology portfolio for over 40 different indications, addressing cancers with unmet needs through clinical trials on a global scale.
In Australia, Daiichi Sankyo is actively cultivating a team dedicated to innovation and compassion for patients. This certification reinforces the organisation’s dedication to cultivating a workplace that encourages employees to balance their professional endeavours with family responsibilities, promoting a harmonious work-life integration.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.
The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Medtech, academia and government unite: Breaking down silos to deliver the power and promise of digital health to patients
MedTech & Diagnostics News: In an interview with Health Industry Hub, Annette Schmiede, CEO of Digital Health Cooperative Research Centre […]
MoreNews & Trends - MedTech & Diagnostics

Two-decade evolution of robotic surgery in Australia’s medical landscape
MedTech & Diagnostics News: In the past two decades, what was once deemed impossible in surgery has now become a […]
MoreNews & Trends - Pharmaceuticals

World-first in IVF: Merging AI and genomics to optimise treatment response for Australians
Pharma News: A world-first Australian IVF study exploring genome sequencing has garnered enthusiastic reception from its collaborative research partners. Securing […]
MoreNews & Trends - Pharmaceuticals

PBS listing marks first oral therapy for childhood arthritis
Pharma News: The first oral Janus kinase (JAK) inhibitor, Pfizer’s Xeljanz (tofacitinib), has been listed on the Pharmaceutical Benefits Scheme […]
More